Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Oct;56(4):413–417. doi: 10.1038/bjc.1987.216

Synergistic inhibitory effects of dipyridamole and vincristine on the growth of human leukaemia and lymphoma cell lines.

M Hirose 1, E Takeda 1, T Ninomiya 1, Y Kuroda 1, M Miyao 1
PMCID: PMC2001816  PMID: 3479994

Abstract

The effects of combinations of dipyridamole, an effective blocker of the salvage pathway of DNA synthesis, and 8 types of anti-cancer drugs on the growth of human T, B and myeloid leukaemia/lymphoma cell lines in vitro were examined. In combinations, dipyridamole and vincristine (VCR), and dipyridamole and vindesine had synergistic inhibitory effects. Dipyridamole reduced the efflux of VCR from cells and enhanced their VCR accumulation in a dose-dependent manner at concentrations of up to 10 microM in the lymphoid cell lines, MOLT-3 and BL-TH, and of up to at least 20 microM in the myeloid cell line, ML-1. Dipyridamole also enhanced the accumulation of VCR in PHA-stimulated and un-stimulated lymphocytes of normal donors, but efflux of VCR was more rapid from normal lymphocytes than from cultured cell lines. It is proposed that combination therapy with dipyridamole plus VCR should be effective in the treatment of leukaemia and lymphoma.

Full text

PDF
415

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berlin R. D., Oliver J. M. Membrane transport of purine and pyrimidine bases and nucleosides in animal cells. Int Rev Cytol. 1975;42:287–336. doi: 10.1016/s0074-7696(08)60983-3. [DOI] [PubMed] [Google Scholar]
  2. Cabral S., Leis S., Bover L., Nembrot M., Mordoh J. Dipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells. Proc Natl Acad Sci U S A. 1984 May;81(10):3200–3203. doi: 10.1073/pnas.81.10.3200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Emmons P. R., Harrison M. J., Honour A. J., Mitchell J. R. Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit. Nature. 1965 Oct 16;208(5007):255–257. doi: 10.1038/208255a0. [DOI] [PubMed] [Google Scholar]
  4. Farmer J. L., Prager M. D. Inhibition of lymphoproliferation by dipyridamole. Biochem Pharmacol. 1982 Apr 1;31(7):1381–1386. doi: 10.1016/0006-2952(82)90032-6. [DOI] [PubMed] [Google Scholar]
  5. Fischer P. H., Pamukcu R., Bittner G., Willson J. K. Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole. Cancer Res. 1984 Aug;44(8):3355–3359. [PubMed] [Google Scholar]
  6. Hirose M., Takeda E., Ninomiya T., Kuroda Y., Miyao M. Inhibitory effect of dipyridamole on the growth of various human hematologic malignant cell lines. Tokushima J Exp Med. 1986 Dec;33(3-4):51–57. [PubMed] [Google Scholar]
  7. Howell S. B., Mansfield S. J., Taetle R. Thymidine and hypoxanthine requirements of normal and malignant human cells for protection against methotrexate cytotoxicity. Cancer Res. 1981 Mar;41(3):945–950. [PubMed] [Google Scholar]
  8. Kessel D., Dodd D. C. Effects of persantin on several transport systems of murine leukemias. Biochim Biophys Acta. 1972 Oct 23;288(1):190–194. doi: 10.1016/0005-2736(72)90237-4. [DOI] [PubMed] [Google Scholar]
  9. King M. E., Naporn A., Young B., Howell S. B. Modulation of cytarabine uptake and toxicity by dipyridamole. Cancer Treat Rep. 1984 Feb;68(2):361–366. [PubMed] [Google Scholar]
  10. Minowada J., Onuma T., Moore G. E. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst. 1972 Sep;49(3):891–895. [PubMed] [Google Scholar]
  11. Nelson J. A., Drake S. Potentiation of methotrexate toxicity by dipyridamole. Cancer Res. 1984 Jun;44(6):2493–2496. [PubMed] [Google Scholar]
  12. PABST H. W. Uber die Wirkung einer neuen coronarerweiternden Substanz: 2, 6-Bis (diäthanolamino)-4, 8-dipiperidino-pyrimido (5,4-d)pyrimidin. Med Klin. 1959 Feb 13;54(7):257–260. [PubMed] [Google Scholar]
  13. Paterson A. R., Lau E. Y., Dahlig E., Cass C. E. A common basis for inhibition of nucleoside transport by dipyridamole and nitrobenzylthioinosine? Mol Pharmacol. 1980 Jul;18(1):40–44. [PubMed] [Google Scholar]
  14. Pazdur J., Krzystyniak K., Kopeć M. Effects of dipyridamole on human blood lymphocytes. Biochem Pharmacol. 1980 Sep 15;29(18):2515–2517. doi: 10.1016/0006-2952(80)90358-5. [DOI] [PubMed] [Google Scholar]
  15. Pinedo H. M., Zaharko D. S., Bull J. M., Chabner B. A. The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides. Cancer Res. 1976 Dec;36(12):4418–4424. [PubMed] [Google Scholar]
  16. Scholtissek C. Studies on the uptake of nucleic acid precursors into cells in tissue culture. Biochim Biophys Acta. 1968 Jun 24;158(3):435–447. doi: 10.1016/0304-4165(68)90297-3. [DOI] [PubMed] [Google Scholar]
  17. Steel G. G., Peckham M. J. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys. 1979 Jan;5(1):85–91. doi: 10.1016/0360-3016(79)90044-0. [DOI] [PubMed] [Google Scholar]
  18. Takeda E., Hirose M., Kuroda Y., Ninomiya T., Toshima K., Watanabe T., Ito M., Naito E., Miyao M. Ribonucleotide reductase and thymidine kinase activities in various cultured cell lines derived from hematologic malignancies. Gan. 1984 Sep;75(9):816–823. [PubMed] [Google Scholar]
  19. Tsuruo T., Iida H. Effects of cytochalasins and colchicine on the accumulation and retention of daunomycin and vincristine in drug resistant tumor cells. Biochem Pharmacol. 1986 Apr 1;35(7):1087–1090. doi: 10.1016/0006-2952(86)90143-7. [DOI] [PubMed] [Google Scholar]
  20. Zhen Y. S., Lui M. S., Weber G. Effects of acivicin and dipyridamole on hepatoma 3924A cells. Cancer Res. 1983 Apr;43(4):1616–1619. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES